Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 5, May, p. 593–599

doi: 10.17219/acem/83695

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Histological examinations of the in vivo biocompatibility of oxycellulose implanted into rat skeletal muscle

Christiane Kunert-Keil1,C,D, Isabel Narath1,B, Jakub Hadzik2,D, Tomasz Gedrange1,A, Tomasz Gredes1,E, Marzena Dominiak2,F

1 Department of Orthodontics, Carl Gustav Carus Campus, Technische Universität Dresden, Germany

2 Department of Dental Surgery, Faculty of Dentistry, Wroclaw Medical University, Poland

Abstract

Background. Recently it was shown that oxycellulose suppressed bone regeneration led to an accumulation of connective tissue as well as foam cells in bone defects.
Objectives. Since oxycellulose can be used as a hemostatic agent in general and dental surgery, the aim of the study was to examine muscle tissue response to implanted oxidized cellulose.
Material and Methods. RESO-Cell® (Resorba Wundversorgung GmbH, Nuremberg, Germany) standard was implanted in the latissimus dorsi of 20 rats; subsequently, 12 samples were processed for histological evaluation after 4 and 8 weeks. The remaining 8 samples were processed for mRNA expression analyses of gene-encoding growth factors and collagens using quantitative reverse transcription polymerase chain reaction (RT-qPCR).
Results. Muscle tissue exposed to oxycellulose showed elevated mRNA levels of COL1A1 compared to untreated muscle tissue. The histological analysis revealed that no undegraded oxycellulose was detectable after as little as 4 weeks. Furthermore, a strong accumulation of CD68-positive foam cells was found in the treated area.
Conclusion. In conclusion, the study has shown that oxidized cellulose can cause an inflammatory response after this material is implanted in skeletal muscle. Therefore, it is not recommended to leave this material in the body over a long period. However, it could be used as auxiliary material in the treatment of periodontal defects.

Key words

skeletal muscle, implantation, qPCR, oxidized cellulose, histiocytic reaction

References (40)

  1. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury. 2005;36:(Suppl 3):S20–S27.
  2. Kunert-Keil C, Gredes T, Gedrange T. Biomaterials applicable for alveolar sockets preservation: In vivo and in vitro studies. In: Turkyilmaz, I, ed(s). Implant Dentistry – The Most Promising Discipline of Dentistry. London, UK: InTech; 2011. Published on October 3, 2011. doi: 10.5772/18459
  3. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials. 2000;21(33):2347–2359.
  4. Coombes AG, Meikle MC. Resorbable synthetic polymers as replacements for bone graft. Clin Mater. 1994;17(1):35–67.
  5. Razak SA, Sharif N, Rahman W. Biodegradable polymers and their bone applications: A review. International Journal of Basic & Applied Sciences. 2012;12(1):31–49.
  6. Moire L, Rezzonico E, Poirier Y. Synthesis of novel biomaterials in plants. J Plant Physiol. 2003;160(7):831–839.
  7. Gredes T, Kunert-Keil C, Dominiak M, Gedrange T, Wróbel-Kwiatkowska M, Szopa J. The influence of biocomposites containing genetically modified flax fibers on gene expression in rat skeletal muscle. Biomed Tech (Berl). 2010;55(6):323–329.
  8. Gredes T, Wrobel-Kwiatkowska M, Dominiak M, Gedrange T, Kunert-Keil C. Osteogenic capacity of transgenic flax scaffolds. Biomed Tech (Berl). 2012;57(1):53–58.
  9. Kunert-Keil C, Gredes T, Meyer A, Wróbel-Kwiatkowska M, Dominiak M, Gedrange T. The survival and proliferation of fibroblasts on biocomposites containing genetically modified flax fibers: An in vitro study. Ann Anat. 2012;194(6):513–517.
  10. Zini E, Scandola M. Green composites: An overview. Polym Compos. 2011;32(12):1905–1915.
  11. Kraitzer A, Kloog Y, Zilberman M. Novel farnesylthiosalicylate (FTS)-eluting composite structures. Eur J Pharm Sci. 2009;37(3–4): 351–362.
  12. van Dam JEG, van Vilsteren GET, Zomers FHA, et al. Increased application of domestically produced plant fibers in textile, pulp and paper production, and composite materials. Industrial Fiber Crops, European Commission Directorate-General XII. 1996.
  13. Skórkowska-Telichowska K, Zuk M, Kulma A, et al. New dressing materials derived from transgenic flax products to treat long-standing venous ulcers: A pilot study. Wound Repair Regen. 2010;18(2):168–179.
  14. Bajerova M, Krejcova K, Rabiskova M, et al. Oxycellulose: Significant characteristics in relation to its pharmaceutical and medical application. Advances in Polymer Technology. 2009;28(3):199–208.
  15. Bechstein WO, Strey C. Local and systemic hemostasis in surgery [in German]. Chirurg. 2007;78(2):95–96,98–100.
  16. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: Bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004; 13(Suppl 1):S89–S96.
  17. Kunert-Keil C, Hadzik J, Grewe I, et al. Osteogenic potential of oxycellulose: A molecular-biological and histological study in rats. J Cytol Histol. 2015;6:1–5.
  18. Kollar P, Suchy P, Muselik J, Bajerová M, Havelka P, Sopuch T. Hemostatic effects of oxidized cellulose [in Czech]. Ceska Slov Farm. 2008; 57(1):11–16.
  19. Levy ML, Amar AP. The use of oxidized regenerated cellulose in neurosurgical procedures. Surg Technol Int. 1998;7:467–471.
  20. Pollack RP, Bouwsma OJ. Applications of oxidized regenerated cellulose in periodontal therapy: Part 1. Compendium. 1992;13(10):888, 890,892 passim.
  21. Franceschini G, Visconti G, Masetti R. Oncoplastic breast surgery with oxidized regenerated cellulose: Appraisals based on five-year experience. Breast J. 2014;20(4):447–448.
  22. Franceschini G, Visconti G, Sanchez AM, Di Leone A, Salgarello M, Masetti R. Oxidized regenerated cellulose in breast surgery: Experimental model. J Surg Res. 2015; 198(1):237–244.
  23. Franceschini G, Visconti G, Terribile D, et al. The role of oxidized regenerate cellulose to prevent cosmetic defects in oncoplastic breast surgery. Eur Rev Med Pharmacol Sci. 2012;16(7):966–971.
  24. Burugapalli K, Pandit A. Characterization of tissue response and in vivo degradation of cholecyst-derived extracellular matrix. Biomacromolecules. 2007;8(11):3439–3451.
  25. Burugapalli K, Thapasimuttu A, Chan JC, et al. Scaffold with a natural mesh-like architecture: Isolation, structural, and in vitro characterization. Biomacromolecules. 2007;8(3):928–936.
  26. Kunert-Keil C, Scholz F, Gedrange T, Gredes T. Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects: A molecular-biological and histological study. Ann Anat. 2015;199:79–84.
  27. Gredes T, Spassov A, Mai R, et al. Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants. J Physiol Pharmacol. 2009;60(Suppl 3):77–81.
  28. Moryganov AP, Galashina VN, Dymnikova NS, Danilov AR. Modification of flax fibres: From research to realization. Fibre Chemistry. 2008;40(3):234–240.
  29. Szopa J, Wrobel-Kwiatkowska M, Kulma A, et al. Chemical composition and molecular structure of fibers from transgenic flax producing polyhydroxybutyrate, and mechanical properties and platelet aggregation of composite materials containing these fibers. Compos Sci Technol. 2009;69(14):2438–2446.
  30. Maijala P, Makinen M, Galkin S, Fagerstedt K, Härkäsalmi T, Viikari L. Enzymatic modification of flaxseed fibers. J Agric Food Chem. 2012; 60(44):10903–10909.
  31. Frantz VK. Absorbable cotton, paper and gauze: (oxidized cellulose). Ann Surg. 1943;118(1):116–126.
  32. Galgut PN. Oxidized cellulose mesh. I. Biodegradable membrane in periodontal surgery. Biomaterials. 1990;11(8):561–564.
  33. Tefik T, Sanli O, Oktar T, Yucel OB, Ozluk Y, Kilicaslanb I. Oxidized regenerated cellulose granuloma mimicking recurrent mass lesion after laparoscopic nephron sparing surgery. Int J Surg Case Rep. 2012; 3(6):227–230.
  34. Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt). 2003;4(3):255–262.
  35. Wagner WR, Pachence JM, Ristich J, Johnson PC. Comparative in vitro analysis of topical hemostatic agents. J Surg Res. 1996;66(2):100–108.
  36. Masova L, Rysava J, Krizova P, et al. Hemostyptic effect of oxidized cellulose on blood platelets. Sb Lek. 2003;104(2):231–236.
  37. Altun I. An experimental study on histopathological effects of hemostatic agents used in spinal surgery. World Neurosurg. 2016;90:147–153.
  38. Lemoy MJ, Schouten AC, Canfield DR. Granuloma due to oxidized regenerated cellulose in an aged rhesus macaque (Macaca mulatta). Comp Med. 2016;66(1):59–62.
  39. Wang H, Chen P. Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report. Oncol Lett. 2013;5(5):1497–1500.
  40. Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: A review. J Artif Organs. 2005;8(3):137–142.
© Wroclaw Medical University